The Discounted Cash Flow (DCF) valuation of Bristol-Myers Squibb Co (BMY) is 59.79 USD. With the latest stock price at 56.29 USD, the upside of Bristol-Myers Squibb Co based on DCF is 6.2%.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.2% | 6.3% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 44.72 - 84.90 | 59.79 |
| Upside | -20.6% - 50.8% | 6.2% |